Mylan

Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst
Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst
Fierce Pharma
Pfizer
Upjohn
Mylan
spinoffs
generics
Flag link:
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Pfizer
Bristol-Myers Squibb
FDA
generics
bloodthinners
Eliquis
Micro Labs
Mylan
Flag link:
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
Flag link:
Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Fierce Pharma
Roche
Mylan
Herceptin
biosimilar
cancer
oncology
Ogivri
Flag link:
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Fierce Pharma
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
Flag link:
Think Mylan's done with M&A after its Pfizer deal? Think again
Think Mylan's done with M&A after its Pfizer deal? Think again
Fierce Pharma
Mylan
Pfizer
M&A
Upjohn
generics
Flag link:
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Flag link:
Thanks, Pfizer: Mylan execs in line for $71M-plus golden parachutes in Upjohn merger
Thanks, Pfizer: Mylan execs in line for $71M-plus golden parachutes in Upjohn merger
Fierce Pharma
Mylan
Pfizer
M&A
executive pay
Flag link:
Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal
Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal
Investors Business Daily
Mylan
SEC
EpiPen
Flag link:
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Mylan
Lantus
generics
Biocon
drug manufacturing
diabetes
Flag link:
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Eli Lilly
Mylan
Alimta
FDA
generics
lung cancer
Flag link:
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Mylan
Eli Lilly
generics
Alimta
non-squamous non-small cell lung cancer
mesothelioma
Flag link:
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Novo Nordisk
Mylan
generics
Victoza
diabetes
Flag link:
3 generic drugmakers accused of 'stonewalling' congressional probe
3 generic drugmakers accused of 'stonewalling' congressional probe
Beckers Hospital Review
generics
Mylan
Teva Pharmaceutical
Heritage Pharmaceuticals
Flag link:
Mylan-Upjohn Merger Leaves Analysts Skeptical
Mylan-Upjohn Merger Leaves Analysts Skeptical
Xtalks
analysts
M&A
Mylan
Pfizer
Upjohn
Flag link:
After Mylan Gets Acquired, Could Teva Be Next?
After Mylan Gets Acquired, Could Teva Be Next?
Yahoo/Guru Focus
Pfizer
Upjohn
Mylan
Teva Pharmaceutical
M&A
Flag link:
Pfizer may send EpiPen manufacturing to generics spinoff
Pfizer may send EpiPen manufacturing to generics spinoff
Biopharma Dive
Pfizer
Mylan
M&A
Meridian Medical Technologies
EpiPens
drug shortages
Flag link:
Plagued by production issues, Pfizer aims to shift EpiPen work to Mylan-Upjohn merger
Plagued by production issues, Pfizer aims to shift EpiPen work to Mylan-Upjohn merger
Fierce Pharma
Mylan
Pfizer
Upjohn
EpiPens
drug shortages
Flag link:
How Mylan ended as a junior partner in its Pfizer deal
How Mylan ended as a junior partner in its Pfizer deal
Biopharma Dive
Mylan
Pfizer
Perrigo
Teva Pharmaceutical
M&A
Flag link:
With Mylan deal, Pfizer seeks faster growth via innovation focus
With Mylan deal, Pfizer seeks faster growth via innovation focus
BioCentury
Pfizer
Mylan
M&A
Upjohn
innovation
Flag link:

Pages